In my humble opinion, DECN isn't the focus of this
Post# of 11802
The company and its lawyers now have three jobs, first to make sure that the FDA processes stay on track with this new distraction, second to make sure that the SEC is mollified even though compared to the other large groups of suspended companies the problems they found with DECN, both of them, are minor. And finally to meet out justice to those that deserve it. The lying and twisting by non-shareholders has gone on way too long.